drugset / Trial / NCT04446884

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells

NCT04446884

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of women with stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Timeline

Start
2018-03-01
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy 6e+06 cells Other